New aspects in vascular gene therapy

被引：20
|
作者：
Karvinen, Henna
Yla-Herttuala, Seppo
机构：
[1] Department of Biotechnology and Molecular Medicine, A.I. Virtanen Institute for Molecular Sciences, University of Eastern Finland
来源：
CURRENT OPINION IN PHARMACOLOGY | 2010年 / 10卷 / 02期
基金：
芬兰科学院;
关键词：
ENDOTHELIAL GROWTH-FACTOR; AAV VECTORS; ANGIOGENESIS; VEGF; MYOCARDIUM; DISEASE; ARTERIOGENESIS; ISCHEMIA; DELIVERY; SAFETY;
D O I：
10.1016/j.coph.2010.01.004
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
Advances in clinical gene therapy have been modest although significant progress has been made during the past few years. New viruses have been introduced and new results have been collected from preclinical and clinical studies. This review will focus on cardiovascular and especially proangiogenic gene therapy. Recent results from preclinical developments and clinical trials will be discussed.
引用
收藏
页码：208 / 211
页数：4
相关论文
共 50 条
  • [1] Current gene therapy trials for vascular diseases
    Halonen, Paavo J.
    Nurro, Jussi
    Kuivanen, Antti
    Yla-Herttuala, Seppo
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2014, 14 (03) : 327 - 336
  • [2] Gene therapy with vascular endothelial growth factors
    Yla-Herttuala, Seppo
    BIOCHEMICAL SOCIETY TRANSACTIONS, 2009, 37 : 1198 - 1200
  • [3] Gene therapy in vascular disease
    Sedighiani, Fazilat
    Nikol, Sigrid
    SURGEON-JOURNAL OF THE ROYAL COLLEGES OF SURGEONS OF EDINBURGH AND IRELAND, 2011, 9 (06): : 326 - 335
  • [4] Gene transfer therapy in vascular diseases
    McKay, MJ
    Gaballa, MA
    CARDIOVASCULAR DRUG REVIEWS, 2001, 19 (03): : 245 - 262
  • [5] Progress and prospects: hurdles to cardiovascular gene therapy clinical trials
    Hedman, M.
    Hartikainen, J.
    Yla-Herttuala, S.
    GENE THERAPY, 2011, 18 (08) : 743 - 749
  • [6] Gene Therapy of Chronic Limb-Threatening Ischemia: Vascular Medical Perspectives
    Simon, Florian
    Duran, Mansur
    Garabet, Waseem
    Schelzig, Hubert
    Jacobs, Michael
    Gombert, Alexander
    JOURNAL OF CLINICAL MEDICINE, 2022, 11 (05)
  • [7] Vascular complications and gene therapy
    Roy, S
    Rothschild, JG
    Chen, A
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2003, 3 (01) : 71 - 83
  • [8] Recent Advancements in Cardiovascular Gene Therapy and Vascular Biology
    Laakkonen, Johanna P.
    Yla-Herttuala, Seppo
    HUMAN GENE THERAPY, 2015, 26 (08) : 518 - 524
  • [9] Vascular endothelial growth factor as a biomarker for endostatin gene therapy
    Braga, Marina Souza
    Turaca, Thiago Lauro
    Foguer, Karen
    Barbosa Chaves, Karen Cristina
    Pesquero, Joao Bosco
    Chammas, Roger
    Schor, Nestor
    Bellini, Maria Helena
    BIOMEDICINE & PHARMACOTHERAPY, 2013, 67 (06) : 511 - 515
  • [10] Gene therapy in vascular medicine: recent advances and future perspectives
    Morishita, R
    Aoki, M
    Kaneda, Y
    Ogihara, T
    PHARMACOLOGY & THERAPEUTICS, 2001, 91 (02) : 105 - 114
12345